Cellavita Pesquisa Científica Ltda Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03252535
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Cellavita Pesquisa Científica Ltda